We have updated our Privacy Policy and Terms of Use for Eurasia Group and its affiliates, including GZERO Media, to clarify the types of data we collect, how we collect it, how we use data and with whom we share data. By using our website you consent to our Terms and Conditions and Privacy Policy, including the transfer of your personal data to the United States from your country of residence, and our use of cookies described in our Cookie Policy.

Your Tuesday author has written about the sharp drop in Vladimir Putin’s approval numbers following unpopular changes announced to Russia’s pension system. That story made news again this week with a new poll that gives United Russia, a party distinguished only by slavish devotion to Putin, an approval rating of just 37 percent. That’s their lowest point since 2011.
Putin isn’t the only autocrat with a headache. After an historic consolidation of power over the past year, one made possible by purges of rivals and a surge in state censorship, President Xi Jinping has established a degree of political dominance not seen in China since the death of Mao Zedong in 1976. But Xi is now grappling with two main sources of anxiety and anger.
The near-term problem is a public health crisis. A party that holds a monopoly on power assumes direct responsibility for the security and wellbeing of its citizens. In years past, China’s people have fallen victim to unsafe food and medicine, and last month a government investigation and news reports revealed that a major Chinese drug company produced at least 250,000 doses of vaccine for diphtheria, tetanus, and whooping cough that didn’t meet safety standards. This is China’s third vaccine scandal in eight years. Protests erupted on social media and on the streets of Chinese cities.The long-term challenge centers on growing economic anxiety. China’s economy has been slowing for years, in part by design, as the leadership shifts from heavy reliance on exports to a model fueled by the spending of Chinese consumers. It hasn’t been a smooth process, and the state has recently had to inject more than $100 billion to keep the economy moving at a healthy pace.
A growing trade war with the US has only added to unease about the future. President Trump again raised the stakes this week with threats to impose 25 percent tariffs on $200 billion worth of Chinese exports to the US.
Last October, as presidential term limits were lifted, and a twice per decade Communist Party congress became a kind of coronation, Xi proclaimed a new era for China, one in which his rising nation need no longer hide its strength and surging self-confidence. Yet, if China’s economic worries continue to grow, some will blame Xi and this triumphalist message for provoking an unnecessary confrontation with the US and others.
Let’s be clear: Xi and Putin have plenty of power in reserve. Neither is in imminent danger. But both must fear that, over time, emboldened critics may limit their ability to take unpopular but necessary steps for the long-term health of their countries.